The procedures by which the Food and Drug Administration approves drugs and medical devices for use in the United States were addressed in a cluster of reports from the Congressional Research Service.
How FDA Approves Drugs and Regulates Their Safety and Effectiveness, June 25, 2012
FDA’s Authority to Ensure That Drugs Prescribed to Children Are Safe and Effective, June 25, 2012
FDA Regulation of Medical Devices, June 25, 2012
The FDA Medical Device User Fee Program, June 25, 2012
Nuclear weapons budgeting is like agreeing to buying a house without knowing the sales price, the mortgage rate, or the monthly payment.
Employing a living approach to evidence synthesis, disseminated at a national level, is a streamlined way to enable evidence-based decision-making nationwide.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.